(Q46122344)

19 December 2017

title

Differential results between self-report and interview-based ratings of risk symptoms of psychosis (English)

1 reference

19 December 2017

1 reference

Niklas Granö

1

1 reference

19 December 2017

Marjaana Karjalainen

2

1 reference

19 December 2017

Arja Itkonen

3

1 reference

19 December 2017

Jukka Anto

4

1 reference

19 December 2017

Virve Edlund

5

1 reference

19 December 2017

Markus Heinimaa

6

1 reference

19 December 2017

Mikko Roine

7

1 reference

19 December 2017

publication date

5 May 2011

1 reference

19 December 2017

Early Intervention in Psychiatry: the development, onset and treatment of emerging mental disorders

published in

1 reference

19 December 2017

volume

5

1 reference

19 December 2017

issue

4

1 reference

19 December 2017

page(s)

309-314

1 reference

19 December 2017

Prospective investigations of the prodromal state of schizophrenia: assessment instruments

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-7893.2011.00266.X

The positive and negative syndrome scale (PANSS) for schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-7893.2011.00266.X

Prodromal assessment with the structured interview for prodromal syndromes and the scale of prodromal symptoms: predictive validity, interrater reliability, and training to reliability

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-7893.2011.00266.X

Psychosis prediction: 12-month follow up of a high-risk ("prodromal") group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-7893.2011.00266.X

Risk factors for psychosis in an ultra high-risk group: psychopathology and clinical features

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-7893.2011.00266.X

Early detection and intervention in the initial prodromal phase of schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-7893.2011.00266.X

Validation of "prodromal" criteria to detect individuals at ultra high risk of psychosis: 2 year follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-7893.2011.00266.X

Prediction of psychosis in adolescents and young adults at high risk: results from the prospective European prediction of psychosis study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-7893.2011.00266.X

Transition and remission in adolescents at ultra-high risk for psychosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-7893.2011.00266.X

Risk and protection in prodromal schizophrenia: ethical implications for clinical practice and future research

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-7893.2011.00266.X

Diagnosing schizophrenia in the initial prodromal phase

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-7893.2011.00266.X

PROD-screen--a screen for prodromal symptoms of psychosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-7893.2011.00266.X

The prodromal questionnaire (PQ): preliminary validation of a self-report screening measure for prodromal and psychotic syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-7893.2011.00266.X

Psychotic-like experiences in a community sample of adolescents: implications for the continuum model of psychosis and prediction of schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-7893.2011.00266.X

Early self-experienced neuropsychological deficits and subsequent schizophrenic diseases: an 8-year average follow-up prospective study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-7893.2011.00266.X

The PRIME North America randomized double-blind clinical trial of olanzapine versus placebo in patients at risk of being prodromally symptomatic for psychosis. II. Baseline characteristics of the "prodromal" sample

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-7893.2011.00266.X

What is the relative importance of self reported psychotic symptoms in epidemiological studies? Results from the ESEMeD--Catalonia Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-7893.2011.00266.X

Self‐reported psychotic experiences in the general population: a valid screening tool for DSM‐III‐R psychotic disorders?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-7893.2011.00266.X

Lifetime prevalence, demographic risk factors, and diagnostic validity of nonaffective psychosis as assessed in a US community sample. The National Comorbidity Survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-7893.2011.00266.X

Are self-reports valid for schizophrenia patients with poor insight? Relationship of unawareness of illness to psychological self-report instruments.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-7893.2011.00266.X

Prepsychotic phase of schizophrenia and related disorders: recent progress and future opportunities

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-7893.2011.00266.X

„Selbstscreen-Prodrom” – Ein Selbstbeurteilungsinstrument zur Früherkennung von psychischen Erkrankungen und Psychosen

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-7893.2011.00266.X

10.1111/J.1751-7893.2011.00266.X

21 January 2018

Identifiers

DOI

1 reference

19 December 2017

1 reference

19 December 2017